Franklin Resources’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5M | Buy |
4,301,123
+151,262
| +4% | +$1.42M | 0.01% | 695 |
|
|
2025
Q1 | $22.5M | Buy |
4,149,861
+12,294
| +0.3% | +$66.6K | 0.01% | 867 |
|
|
2024
Q4 | $30.8M | Buy |
4,137,567
+125,519
| +3% | +$935K | 0.01% | 775 |
|
|
2024
Q3 | $40.8M | Buy |
4,012,048
+362,399
| +10% | +$3.69M | 0.01% | 672 |
|
|
2024
Q2 | $31.8M | Buy |
3,649,649
+260,412
| +8% | +$2.27M | 0.01% | 705 |
|
|
2024
Q1 | $70.1M | Sell |
3,389,237
-1,251,414
| -27% | -$25.9M | 0.02% | 468 |
|
|
2023
Q4 | $107M | Buy |
4,640,651
+488,206
| +12% | +$11.3M | 0.05% | 343 |
|
|
2023
Q3 | $33.2M | Sell |
4,152,445
-912,138
| -18% | -$7.29M | 0.02% | 611 |
|
|
2023
Q2 | $44.1M | Sell |
5,064,583
-713,557
| -12% | -$6.21M | 0.02% | 563 |
|
|
2023
Q1 | $17M | Buy |
5,778,140
+3,631
| +0.1% | +$10.7K | 0.01% | 817 |
|
|
2022
Q4 | $20.2M | Buy |
5,774,509
+164,632
| +3% | +$576K | 0.01% | 769 |
|
|
2022
Q3 | $44.4M | Buy |
5,609,877
+159,624
| +3% | +$1.26M | 0.02% | 553 |
|
|
2022
Q2 | $42.9M | Buy |
5,450,253
+130,425
| +2% | +$1.03M | 0.02% | 587 |
|
|
2022
Q1 | $64.6M | Buy |
5,319,828
+372,663
| +8% | +$4.53M | 0.03% | 530 |
|
|
2021
Q4 | $60.6M | Buy |
4,947,165
+1,772,828
| +56% | +$21.7M | 0.02% | 586 |
|
|
2021
Q3 | $33.1M | Buy |
3,174,337
+377,664
| +14% | +$3.94M | 0.01% | 768 |
|
|
2021
Q2 | $25.1M | Sell |
2,796,673
-91,574
| -3% | -$823K | 0.01% | 807 |
|
|
2021
Q1 | $29.3M | Buy |
2,888,247
+1,474,300
| +104% | +$15M | 0.01% | 752 |
|
|
2020
Q4 | $9.3M | Buy |
1,413,947
+1,000,197
| +242% | +$6.58M | ﹤0.01% | 973 |
|
|
2020
Q3 | $2.14M | Hold |
413,750
| – | – | ﹤0.01% | 1192 |
|
|
2020
Q2 | $3.11M | Hold |
413,750
| – | – | ﹤0.01% | 1062 |
|
|
2020
Q1 | $4.22M | Buy |
+413,750
| New | +$4.22M | ﹤0.01% | 954 |
|